Published in
American Association for the Advancement of Science, Science Translational Medicine, 290(7), 2015
DOI: 10.1126/scitranslmed.aaa9301
Links
Tools
Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients
Journal article published in 2015 by
Helen Benham,
Hendrik J. Nel,
Ahmed M. Mehdi,
Shayna Street,
Nishta Ramnoruth,
Helen Pahau,
Jennifer Ng,
Leendert A. Trouw,
Anthony W. Purcell 
,
Brendan J. O'Sullivan,
Sanjoy K. Paul,
Kim-Anh Lê Cao,
Ranjeny Thomas,
Soi Cheng Law ,
Marion E. G. Brunck
and other authors.
,
Brendan J. O'Sullivan,
Sanjoy K. Paul,
Kim-Anh Lê Cao,
Ranjeny Thomas,
Soi Cheng Law ,
Marion E. G. Brunck
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Citrullinated peptide-exposed DCs induced immune regulatory effects in HLA risk genotype–positive RA patients.